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http://dx.doi.org/10.1016/j.tmaid.20Summary Background: Previous studies investigating the travellers’ knowledge, attitudes
and practices (KAP) profile indicated an important educational need among those travelling
to risk destinations.
Methods: In the years 2002e2009 an annually repeated cross-sectional questionnaire-based
survey was conducted at the Dutch Schiphol Airport with the aim to study trends in KAP of
travel risk groups toward prevention of hepatitis B. The frequently encountered risk groups
last-minute travellers, solo-travellers, business travellers, travellers visiting friends and rela-
tives (VFR) and elderly travellers were specifically studied.
Results: A total of 3045 respondents were included in the survey. Travellers to destinations
with a high risk for hepatitis B had significantly less accurate risk perceptions (knowledge) than
travellers to low-risk destinations but no differences were observed in past risk-taking atti-
tude. Protection rates against hepatitis B were significantly higher in travellers to high-risk
destinations. There was a positive trend over the years in the proportion of travellers to
high-risk destinations seeking travel health advice. In accordance with this, trend analyses alsoital and Institute for Tropical Diseases, Haringvliet 72, 3011 TG Rotterdam, The Netherlands. Tel.:
.
havenziekenhuis.nl, pjjvangenderen@travelclinic.com (P.J.J. van Genderen).
3 Elsevier Ltd. All rights reserved.
13.09.002
150 P.J.J. van Genderen et al.indicated rising protection rates against hepatitis B. No significant trends in protection over
time were observed for the travel risk groups.
Conclusions: The results of this repeated cross-sectional survey suggest an annual 10% increase
in protection rates against hepatitis B in Dutch travellers, both to destinations with a high risk
and to destinations with a lower risk of hepatitis B, but these trends in protection rates were
not observed for the travel risk groups to high-risk destinations. The KAP profile of last-minute
travellers and (to a lesser extent) VFRs showed an increased relative risk in hepatitis B, irre-
spective of the travel destination, underlining the need for specific targeting of these travel
risk groups.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Even though the risk of hepatitis B, a common vaccine-
preventable disease, has been best documented in
extended-stay travellers like expatriates, short-stay trav-
ellers are also at risk and usually unwittingly [1e4]. For
example, a study among 1090 Danish travellers who visited
hepatitis B endemic countries found that 7% of travellers
were exposed to a possible hepatitis B risk situation, which
was either a voluntary risk (1.6%) such as acupuncture,
cosmetic surgery, tattoos, or unprotected sexual contact
with local people, or an involuntary risk (5.4%) such as
medical and dental procedures, blood transfusions, or
medical aid [5]. Interestingly, a higher proportion of trav-
ellers with short trip duration had voluntary risks whereas
those with longer trip durations had a higher rate of
involuntary risks [5].
In the years 2002e2003 the European Travel Health
Advisory Board conducted a cross-sectional pilot survey in
several European airports including the Dutch Schiphol
Airport to evaluate current travel health knowledge, atti-
tude and practice (KAP) toward prevention of travel-
related infectious diseases like hepatitis B [6]. They found
that more than two-third of travellers to developing coun-
tries were not vaccinated against hepatitis B [6]. These low
immunization rates are in line with the findings of other
studies where 57e76% travelled non-immune (based on
immunization history) [5,7]. Speculatively, these data also
suggest that many health care providers probably do not
routinely offer hepatitis B vaccination to unprotected
travellers, even though hepatitis B may pose as a significant
exposure-related health risk. In a large UK study, for
instance, 12% of the hepatitis B cases were considered to be
acquired during travel with medical treatment abroad and
sexual contacts as the most frequently reported routes of
transmission [8].
The results of the airport studies also demonstrated an
important educational need among those travelling to risk
destinations and that all groups of travellers should be
targeted. In the Netherlands, the airport survey has been
done each year between 2002 and 2009 (except for the year
2006), giving a unique opportunity to study trends in KAP of
travellers toward prevention of hepatitis B. Among the
travellers, last-minute travellers, solo-travellers, business
travellers, travellers visiting friends and relatives (VFR), as
well as elderly travellers are thought to belong to groups
with an increased risk for travel-related health issues.These aforementioned frequently encountered travel risk
groups were therefore specifically studied. In the present
study we report the findings regarding the KAP of these
travel risk groups toward prevention of hepatitis B, a
vaccine-preventable infectious disease.Methods
Questionnaires and survey
The survey was conducted as previously described [9]. In
brief, self-administered, anonymous questionnaires were
randomly distributed at the departure gate of Schiphol
Airport, Amsterdam, The Netherlands, while passengers
were waiting to board. Intercontinental flights to destina-
tions with an intermediate or high risk for hepatitis A,
hepatitis B or malaria were preferably selected. The survey
was always done in the same period of the year, namely the
months October or November. Travellers participated on a
voluntary basis; no incentive was provided, except for a
leaflet with information on hepatitis A, hepatitis B and
malaria. Trained interviewers were present to distribute the
questionnaires, to answer questions if necessary and to
check the completeness of the responses collected. When
possible, these interviewers copied the information from
the travellers’ vaccination records. Travellers were allowed
to participate if they were 18 years of age or older, and able
to fully understand the language of the questionnaires. They
also had to be resident in the Netherlands; thus, nationals of
a developing country were only asked to participate if they
were actually living in the Netherlands. These criteria were
checked by the interviewers when distributing the forms.
Afterwards, completed questionnaires from travellers who
did not meet all the inclusion criteria were either excluded
by the interviewers or rejected from the final analysis.
Two kinds of questionnaires were distributed among the
participants, depending on the precise destination. The
malaria questionnaire (Q-mal) focused on malaria and its
prevention and treatment and these questionnaires were
distributed only to travellers with destinations in or close to
malaria-endemic areas. The vaccine questionnaire (Q-vacc)
targeted hepatitis A and B. However, both questionnaires
had a common part on personal characteristics (age,
gender, nationality, residence, profession), on information
regarding the travel (destination, duration, purpose, travel
companions) and its preparation, and on the travellers’
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at their destination. In addition, since most malaria-
endemic countries also carry a high risk for hepatitis A
and B, the Q-mal questionnaire also contained several
similar items in the Q-vacc questionnaire dealing with the
KAP towards prevention of hepatitis A and B, which were
therefore included in the analysis.
Definitions of risk groups
Respondents with an age over 60 years were arbitrarily
classified as elderly travellers. Solo-travellers were defined
as those travellers who travelled alone. Business travellers
were defined as those travellers who specifically stated
that their main purpose for travel was business-related.
Last-minute travellers were defined as those travellers who
did not seek pre-travel health advice or sought it only
within 2 weeks before departure. Respondents who spe-
cifically stated that their main purpose for travel was to
visit friends and relatives were considered VFRs.
Determination of KAP profile on hepatitis B
Knowledge of hepatitis B was determined by comparison of
the prevalence of hepatitis B in the country of destination
as perceived by the traveller with the actual prevalence of
hepatitis B, as depicted in Fig. 1. To that end, all destina-
tions (including those in malaria-endemic countries) were
rated as low, intermediate or high-risk destination for
hepatitis B based on maps published by the Center for
Disease Control, Atlanta, United States of America [10].
Countries with a mixed intermediate-high risk profile
(e.g., Brazil) were considered high risk countries since de-
tails of the travel within a given country were lacking. For
each subject the accuracy (correct risk perception) was
expressed as 0 or 1, with 1 assigned to a subject if his (her)Fig. 1 Prevalence of chronic infection with hepatitis B virus, 20
Health information for International Travel (Yellow Book) 2010 [10knowledge about risk was compatible with the official risk
rating of the destination. To determine the risk-taking
attitude of participants, all participants were asked if
they at a previous journey: 1. had an injury or accident
requiring treatment in hospital (3 points); 2. had undergone
tattooing or piercing during travel (3 points); 3. had sexual
contact with local people (2 points); 4. had shaving with a
local barber (1 point). Each affirmative answer was scored
with the designated number of points whereas a negation
was scored with 0 points. The final risk-taking attitude
score was obtained as the sum of the separate answer
scores and could therefore range from 0 to 9; for conve-
nience and without loss of generality, the score was
transformed to a 0e100 scale with the maximal risk atti-
tude score set at 100. To have an indication of their prac-
tice toward prevention of hepatitis B (immunization rate),
protection was defined as 0 or 1, with 1 assigned to trav-
ellers with either natural immunity, reporting vaccination
for this journey or fully vaccinated in the past (at least 3
doses). Other preventive measures for hepatitis B, like
actual condom use or single-use needles were not included
in the practice scores. In order to estimate the impact of
KAP of the travel risk group of interest on relative risk for
hepatitis B, an aggregate risk estimate was constructed by
summing up the effects of the separate determinants. To
that end, it was assumed that either a poor risk perception,
risk-seeking behaviour or poor protection rates led to an
equal increase in relative risk for hepatitis B.
Statistical analysis
Several statistical analyses were made between travellers
to high and low-risk destinations. Differences in general
characteristics between the two different risk destinations
were tested using multiple logistic regression analyses,
adjusted for subpopulation (maximally 14 subpopulations:06 (adapted from Map 2-2 for the Center for Disease Control
]).
Fig. 2 Flowchart of the Dutch Schiphol Airport Survey. The
yearly inclusions of respondents of the malaria questionnaires
(Q-mal) and vaccination questionnaires (Q-vacc) in the study
are shown as well as reasons for exclusion.
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logistic regression analyses with adjustment for subpopu-
lation were done for testing differences in risk (e.g., yes vs
no VFR as independent variable) between the two knowl-
edge groups (accurate risk perception y/n as dependent
variable) and the two practice groups (protected y/n as
dependent variable), allowing separate tests within low
and within high-risk destinations through entering the
appropriate interaction terms with destination risk into the
models (the “within hepatitis B risk destination” analyses).
The dependency of the attitude scores on the risk factors
was analysed using multiple linear regression analyses,
modelled similarly to the above mentioned logistic regres-
sion analyses. The regression analyses also allow testing
differences between the two risk destination groups in
knowledge, attitude and practice within specific risk groups
(the “between hepatitis B risk destinations” analyses). By
entering the year-by-questionnaire subgroup covariates in
the model for explaining knowledge, attitude or practice a
properly averaged explanatory effect of the risk factors
across the maximally 7 years and two questionnaires was
obtained. It was also tested by entering the appropriate
interaction terms with time as trend variable in the multi-
ple logistic and linear regression models if the strength of
the effect of the predetermined risk factors on knowledge,
attitude and practice showed a significant time trend over
the years 2002e2009 within low as well as within high-risk
destinations. In order to judge how risk factors might have
confounded each other in their effects on knowledge,
attitude and practice, we calculated the correlations of the
risk factors. Additional logistic regression analyses were
performed in order to investigate how seeking travel health
advice (y/n) and hepatitis B risk destination (high/low)
depend on risk factors, adjusted for the year-by-
questionnaire subgroups or with year as explanatory time
trend variable.
Results
Study population
Across all 7 years in the period from 2002 to 2009 (except
year 2006) a total of 3050 questionnaires were received, of
which 3045 fulfilled the entry criteria and were included in
the analysis (Fig. 2). Of the 3045 respondents, 1394 re-
spondents travelled to destinations with a high risk for
hepatitis B. The remaining 1651 respondents travelled to a
low-to-intermediate hepatitis B risk destination. The gen-
eral characteristics of all respondents, grouped by hepatitis
B risk in high and low-to-intermediate risk destinations, are
shown in Table 1. Overall, 46.4% of responders were female
and 53.6% were male.
Travel profile
For 20.8% of the travellers since 2004 it was their first trip
to a developing country (there was no first-trip-item in the
questionnaires of 2002 and 2003). Overall, 63.9% indicated
tourism as their purpose of travel. One in five to six re-
sponders were visiting friends and relatives, business trav-
ellers accounted for 15.0%. Few responders travelled formissionary reasons or for voluntary missions (2.2%), for
purpose of research or education (0.7%) or for other reasons
(1.0%). Many travellers (41.6%) were accompanied by their
partner or spouse; 869 persons (30.3%) were travelling
alone, 6.9% with friends, 11.7% with children.
Travellers to high hepatitis B risk destinations planned to
stay significantly longer on their destination than travellers to
lower-risk destinations (p < 0.001) and obtained pre-travel
health advice more frequently prior to departure
(p < 0.001). Overall, 24.1% went abroad for 1e7 days, 40.2%
for 8e14 days, 26.1% for 15e28 days, and 9.5% for more than
28 days. Gambia was the most common high-risk destination
(26.8%), followed by Thailand (12.6%) and China (12.3%)
whereas among the low-to-intermediate risk destinations
Table 1 General characteristics of 3045 respondents in relation to the hepatitis B risk profile of their destination.
High-risk
destination
Low-to-
intermediate risk
destination
p-Valueb
N % N %
1394 45.8 1651 54.2
Sex <0.001
Male 812 58.2a 811 49.1a
Female 572 41.0 831 50.3
Age 0.041
Age >60 yrs 236 16.9 203 12.3
Travel duration <0.001
<7 days 270 19.4 430 26.0
8e14 days 443 31.8 725 43.9
15e28 days 401 28.8 357 21.6
>28 days 207 14.8 70 4.2
Travel health preparation
Pre-travel information <0.001
No 334 24.0 717 43.4
Yes 1060 76.0 934 56.6
Information source 0.004
Travel clinic/public health service 597 42.8 414 25.1
Company doctor 36 2.6 29 1.8
General practitioner/pharmacy 151 10.8 197 11.9
Other 74 5.3 68 4.1
Time frame booking e departure n.s.
<7 days 116 8.3 115 7.0
8e14 days 180 12.9 134 8.1
15e28 days 275 19.7 226 13.7
>28 days 489 35.1 459 27.8
Purpose for travel <0.001
Tourist 778 55.8 1149 69.6
Business 285 20.4 168 10.2
VFR 230 16.5 291 17.6
Missionary/volunteer 59 4.2 6 0.4
Research 14 1.0 7 0.4
Other 16 1.1 15 0.9
Travel profile <0.001
Solo traveller 457 32.8 412 25.0
Travel with spouse 559 40.1 635 38.5
Travel with children 91 6.5 244 14.8
Travel with group 76 5.5 77 4.7
Travel with friends 88 6.3 110 6.7
Other 47 3.4 72 4.4
Travel experience (intercontinental) in last 5 years 0.011
No 203 14.6 292 17.7
Yes 899 64.5 982 59.5
Top 5 destinations Top 5 destinations
Gambia 373 26.8 428 25.9 Turkey
Thailand 176 12.6 418 25.3 Egypt
China 172 12.3 179 10.8 Mexico
Brazil 143 10.3 170 10.3 Morocco
Indonesia 68 4.9 101 6.1 Surinam
a All data are given as a percentage of either the total number of respondents to high-risk destinations (i.e., n Z 1394) or as a
percentage of the total number of respondents to low-risk destinations (i.e., n Z 1651).
b p-Value for comparison of high-risk destinations vs low-to-intermediate risk destinations, adjusted for questionnaire type and
interview year.
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by the Egypt (25.3%) and Mexico (10.8%) (Table 1).
Travel health preparations
The majority of travellers (65.5%) had sought health infor-
mation about their destination prior to departure. This was
done more than 1 month before leaving by 47.5% of the
responders; 25.1% started preparing 2 weeks to 1 month
before departure, 15.7% did so 1e2 weeks in advance, and
11.6% did so less than 1 week before leaving.
Of those who had not sought health information, the ma-
jority stated that they already knew what to do. The most
common sources since 2004 for travel health advice to high-
risk destinationswere the travel clinic or public health service
(42.8%) followed by general practitioner (GP) or family doctor
in 10.8% of the respondents. For low-risk destinations the
travel clinic or public health service was consulted less
frequently in 25.1% of the respondents whereas the GP or
family doctorwas consulted in 11.9% of the cases (pZ 0.004).
In the 2002- and 2003-questionnaires there was no item con-
cerning source of advice. There was a significant positive
trendover theyears in theproportion of travellers tohigh-risk
destinations seeking travel health advice (odds ratio 1.21 per
year; 95% CI: 1.07e1.37; pZ 0.002), adjusted for question-
naire type, VFR traveller, elderly traveller, business traveller,
solo traveller and length of travel.
Travel risk groups
The group of elderly travellers comprised 439 respondents.
Of them, 236 (16.9%) travelled to a high-risk destination. The
group of last-minute travellers comprised of 545 re-
spondents; 296 (54.3%) of them travelled to a high-risk
destination. Of all respondents, 869 respondents travelled
alone and were classified as solo-travellers; 457 (52.6%) of
them travelled to a high-risk destination. The group of busi-
ness travellers consisted of 453 individuals of whom 285
(62.9%) travelled to destinations rated as a high-risk desti-
nation. The group of VFRs consisted of 521 respondents; 230
(44.1%) of them travelled to a high-risk destination (Table 1).
Knowledge, attitude and practice on hepatitis B
Analysis of risk groups
1. Elderly travellers
Elderly aged travellers visited high-risk destinations signif-
icantly more frequently (Table 1: p Z 0.041, adjusted for
subpopulation) than younger aged travellers. Elderly trav-
ellers to either high-risk or low-risk destinations did not
seek pre-travel information significantly more often than
younger aged travellers to the same risk destination
(p Z 0.39 for low risk and p Z 0.52 for high-risk destina-
tions, adjusted for subpopulation). The knowledge, atti-
tude and practice of elderly travellers to high-risk
destinations were comparable to that of younger travellers
to same risk destinations (Table 2). As a consequence, as
shown in Table 3, the relative risk of elderly travellers for
hepatitis B was comparable with that of younger travellers.2. Solo-travellers
Solo-travellers travelled to high-risk destinations more
often than non-solo-travellers (odds ratio 1.84 (95% CI:
1.54e2.19; p < 0.0005), adjusted for subpopulation). Solo-
travellers to either high (p < 0.0005) or low-risk destina-
tions (p < 0.0005) had less preparation for their travel than
non-solo-travellers to the same risk destination (respective
odds ratios (95% CI’s): 0.52 (0.40e0.68) and 0.49
(0.39e0.62), adjusted for subpopulation). The risk
perception of solo-travellers to high-risk destinations was
comparable to that of non-solo-travellers, whereas past
risk-taking behaviour and protection rates were signifi-
cantly higher (Table 2). As a consequence, the KAP of solo-
travellers to high-risk destinations did not change the
relative risk for hepatitis B (Table 3).
3. Business travellers
Business travellers to either high (p < 0.0005) or low-risk
destinations (p < 0.0005) less frequently sought travel
health advice than non-business travellers (respective odds
ratios (95% CI’s): 0.48 (0.35e0.64) and 0.47 (0.34e0.66),
adjusted for subpopulation). Business travellers travelled
more frequently to high-risk destinations than non-business
travellers (odds ratio 2.88; 95% CI: 2.28e3.63; p < 0.0005,
adjusted for subpopulation). Business travellers to high-risk
destinations had comparable knowledge and risk-taking
attitude as non-business travellers but had significantly
higher protection rates against hepatitis B. As a consequence,
the KAPof business travellers to high-risk destinations slightly
decreased their relative risk for hepatitis B (Table 3).
4. Last-minute travellers
Last-minute travellers went significantly less to high
hepatitis B risk destinations than regular travellers (odds
ratio 0.70; 95% CI: 0.59e0.82; p < 0.0005, adjusted for
subpopulation) and had comparable travel health prepa-
ration in comparison to regular travellers when travelling to
high-risk destinations (p Z 0.35). When travelling to low-
risk destinations, regular travellers consulted the regular
health authorities (GP, company doctor, chemist, municipal
health service) more often than last-minute travellers did
(93.8% vs 83.0%; p < 0.0005, adjusted for subpopulation).
The risk perception and protection rates of last-minute
travellers to high-risk destinations were significantly lower
than that of regular travellers (Table 2). In addition, last-
minute travellers to high-risk destinations had comparable
past risk-taking behaviour than regular travellers. As a
consequence, the KAP of last-minute travellers to high-risk
destinations substantially increased their relative risk for
hepatitis B (Table 3).5. VFRs
VFRs sought less frequently travel health advice than
non-VFR travellers when travelling to low-risk destinations
(odds ratio 0.50; 95% CI: 0.38e0.65; p < 0.0005, adjusted
for subpopulation). For high-risk destinations there was no
significant effect of VFR on seeking health advice
Table 2 Knowledge, attitude and practices of travel risk groups to destinations with high and low-to-intermediate risk for hepatitis B.
Knowledgea High-risk destinations Low-to-intermediate risk destinations p-Value (high vs
low-risk
destinationsf)
# cases # total % p-Value(within
high-risk
destinationsd)
95% confidence
interval of %
# cases # total % p-Value(within
low-risk
destinationse)
95% confidence
interval of %
Overall 343 1394 24.6 n.a. 22.4e27.0 774 1651 46.9 n.a. 44.4e49.3 <0.001
Elderly traveller 67 236 28.4 n.s. 22.7e34.6 81 203 39.9 0.018 33.1e47.0 0.001
Solo-traveller 135 545 24.8 n.s. 21.2e28.6 214 465 46.0 n.s. 41.4e50.7 <0.001
Business-traveller 74 288 25.7 n.s. 20.7e31.2 88 169 52.1 n.s. 52.1e59.8 <0.001
Last-minute traveller 129 630 20.5 0.007 17.4e23.8 398 966 41.2 <0.001 38.1e44.4 <0.001
VFR 57 230 24.8 n.s. 19.3e30.9 115 291 39.5 0.011 33.9e45.4 <0.001
Attitudeb n Mean SD p-Value (within
high-risk
destinationsd)
95% confidence interval
of mean
n Mean SD p-Value (within
low-risk
destinationse)
95% confidence
interval of mean
p-Value (high vs
low-risk
destinationsf)
Overall 899 7.1 14.3 n.a. 6.1e8.1 982 5.9 13.3 n.a. 5.1e6.7 n.s.
Elderly traveller 178 6.4 13.0 n.s. 4.5e8.3 126 4.0 10.6 0.047 2.1e5.9 n.s.
Solo-traveller 382 9.4 16.9 <0.001 7.7e11.1 310 8.2 14.9 0.002 6.5e9.9 n.s.
Business-traveller 219 6.6 14.6 n.s. 4.6e8.6 120 4.1 10.1 n.s. 2.3e5.9 n.s.
Last-minute traveller 438 7.6 15.0 n.s. 6.2e9.0 601 6.2 12.9 n.s. 5.1e7.3 n.s.
VFR 118 13.2 18.7 <0.001 9.8e16.6 159 11.7 17.1 <0.001 9.0e14.4 n.s.
Practicec # cases # total % p-Value (within
high-risk
destinationsd)
95% confidence
interval of %
# cases # total % p-Value (within
low-risk
destinationse)
95% confidence
interval of %
p-Value (high vs
low-risk
destinationsf)
Overall 319 720 44.3 n.a. 40.6e48.0 512 1483 34.5 n.a. 32.1e37.0 <0.001
Elderly traveller 50 121 41.3 n.s. 32.4e50.6 70 171 40.9 n.s. 33.5e48.7 n.s.
Solo-traveller 165 329 50.2 0.003 44.6e55.7 155 436 35.6 n.s. 31.1e40.2 <0.001
Business-traveller 99 185 53.5 0.001 46.0e60.9 70 168 41.7 0.006 34.1e49.5 0.044
Last-minute traveller 132 368 35.9 <0.001 31.0e41.0 257 893 28.8 <0.001 25.8e31.9 0.007
VFR 55 125 44.0 n.s. 35.1e53.2 63 247 25.5 0.001 20.2e31.4 <0.001
All p-Values corrected for questionnaire type and interview year. n.a. Z not applicable; n.s. Z not significant. Last-minute Z information sought: none or within 14 days before
departure.
a Knowledge was defined as a binary 0/1 score (no/yes accurate risk perception); cases were defined as those individuals with accurate
risk perception (score 1).
b Attitude was defined as a continuous risk behaviour score on a 0e100 scale.
c Practice was scored only in the vaccination questionnaires as a binary 0/1 score (no/yes protected); cases were defined as protected
individuals (score 1).
d p-Value of comparison of a given risk group vs the remainder of travellers to a high-risk destination.
e p-Value of comparison of a given risk group vs the remainder of travellers to a low-to-moderate risk destination.
f p-Value of comparison of a given risk group to a high-risk destination vs the same risk group to a low-to-intermediate risk destination.
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156 P.J.J. van Genderen et al.(p Z 0.53, adjusted for subpopulation). There was also no
significant difference in destination-risk between VFRs and
non-VFR travellers (p Z 0.16, adjusted for subpopulation).
The knowledge and practice of VFRs toward prevention of
hepatitis B were comparable to that of non-VFR travellers
to high-risk destinations. However, VFRs had significantly
higher risk-taking behaviour in the past than non-VFR
travellers to high-risk destinations (Table 2). As a conse-
quence, the KAP profile of VFRs slightly increased their
relative risk for hepatitis B (Table 3).
Trends in knowledge, attitudes and practices of travellers
toward prevention of hepatitis B
1. Knowledge (accurate risk perception)
Over the years therewas no significant trend in knowledge for
all travellers to high-risk destinations in contrast to all trav-
ellers toa lower-riskdestination inwhomtheknowledge-odds
increased by 6.2% per year (pZ 0.004; 95% CI 1.9e10.6). Of
the travel risk groups, only in last-minute travellers to low-to-
intermediate risk destinations, a significant downward trend
of 8.6% per year in the knowledge-oddswas observedover the
years (pZ 0.034; 95% CI: 15.8% to 0.7%).
2. Attitude (past-risk taking behaviour)
In travellers to high-risk destinations trend analysis did
not show a significant trend over the years, neither overall
nor in any of the predefined risk groups. In contrast, there
was a significant overall downward trend of 0.48 points
per year in attitude score (scale 0e100) in travellers to low-
to-intermediate risk destination (95% CI: 0.95 to 0.02;
p Z 0.041). Also in VFR travellers to low-to-intermediate
risk destinations a significant downward trend in attitude
score of 1.41 points per year was observed (95% CI: 2.79
to 0.03; p Z 0.045).
3. Practice (protection rate)
In both travellers to high-risk destinations and travellers
to low-to-intermediate risk destinations a significant posi-
tive trend in protection was observed (high-riskTable 3 Estimates of the aggregated impact of the knowledge
relative risk of hepatitis B.
Risk group Knowledge Attitude
Destinations with a known high risk of hepatitis B
Elderly traveller No effect on risk No effect on risk
Solo traveller No effect on risk Increase in risk
Business traveller No effect on risk No effect on risk
Last-minute traveller Increase in risk No effect on risk
VFR No effect on risk Increase in risk
Destinations with a known low-to-intermediate risk of hepatiti
Elderly traveller Increase in risk Decrease in risk
Solo traveller No effect on risk Increase in risk
Business traveller No effect on risk No effect on risk
Last-minute traveller Increase in risk No effect on risk
VFR Increase in risk Increase in riskdestinations: 9.6% increase in the protection-odds per year
(95% CI: 2.4e17.4; pZ 0.008); lower-risk destinations: 9.5%
increase in the protection-odds per year (95% CI 4.6e14.6)).
There were no significant trends observed in protection of
any of the travel risk groups to either high-risk or lower-risk
destinations.Discussion
The results of the European Airport Survey demonstrated an
important educational need among those travelling to risk
destinations and it was suggested that travel health advice
providers should continue their efforts to make travellers
comply with the recommended travel health advice,
especially risk groups [6]. The present study provides in-
depth feedback on these efforts toward prevention of
hepatitis B by analysing the trends in KAP of Dutch travel-
lers, including those belonging to a certain risk group, over
an 8-year observation period.
The results of the current airport study demonstrate
that the immunization rates of hepatitis B of Dutch trav-
ellers to a high-risk destination is 44.3% (95% CI:
40.6e48.0) which seems comparable to that reported for
Danish travellers (43%) [5] and higher than that reported
for Swedish (34%), American (29%) and Australian (28%)
travellers [7,11,12]. However, the definitions of immunity
may have varied between these studies which should be
taken into account before drawing definite conclusions. It
is certainly noteworthy that a significant trend toward
rising immunization rates over time was observed for the
average Dutch traveller, both to high-risk and lower-risk
destinations.
During the study period, the Netherlands had a program
of targeted HBV risk group vaccination rather than uni-
versal vaccination as is practiced in most other countries
in the world. These improved immunization rates may
therefore reflect the continuous efforts of Dutch travel
health advice providers to propagate safe and healthy
travel. The rising trend in travellers to high-risk destina-
tion seeking health advice before commencing travel is in
line with this. Additionally, the observation that in Dutch
travellers the immunization coverage of hepatitis A, attitude and practices (KAP) of travel risk groups on their
Practice Impact on relative risk of hepatitis B
No effect on risk No effect on risk
Decrease in risk No effect on risk
Decrease in risk Slight decrease in risk
Increase in risk Moderate increase in risk
No effect on risk Slight increase in risk
s B
No effect on risk No effect on risk
Decrease in risk No effect on risk
No effect on risk No effect on risk
Increased in risk Moderate increase in risk
Increase in risk Substantial increase in risk
Trends in KAP of travel risk groups toward hepatitis B 157increased in parallel over time, [9] further strengthens
this relationship.
When focussing on the travel risk groups, our results
indicated that the KAP of last-minute travellers, in
particular those travelling to high-risk destinations, sub-
stantially increased their relative risk for hepatitis B. For
destinations with a lower hepatitis B risk this was the case
with VFR travellers and e to a lesser extent e last-minute
travellers. Whether or not advising hepatitis B immuniza-
tion to the short-term traveller remains a subject of
continuous debate. In a previous retrospective study,
Sonder and colleagues [13] investigated the incidence and
risk factors for hepatitis B infection in travellers from
Amsterdam, The Netherlands and found a low incidence of
4.5 per 100,000 travellers. They argued that vaccination
was not deemed necessary for everyone given the fact that
only a small proportion of those considered to be “at risk”
according to behavioural studies actually do acquire the
disease. This point of view is, however, refuted by others
who claim that even if the risk to the individual traveller
from a single trip is low, many infections are expected to
continue to pose risks to travellers during subsequent
travel [5,14]. In addition, administering immunizations like
hepatitis B at an older age may be associated with lower
seroconversion rates due to immunosenescence. A clear
advantage of considering an aggregate risk approach is that
previous vaccination would circumvent many of the po-
tential problems associated with last-minute travel,
including unexpected changes to itineraries and departure
and induction of immunological memory but also requires
discipline for completion of immunization schedules after a
single travel [14,15].
Even though the current study focused on travel desti-
nations with a high risk of hepatitis B, lower-risk destina-
tions may also pose a threat to the unprotected traveller. A
large UK study of hepatitis B incidence and transmission
demonstrated that 12% of the hepatitis B cases were
considered travel-related but that almost half of the cases
(45%) were acquired after travel to a medium endemicity
country [8]. The results of our Airport study suggested that
of the travellers to lower-risk destinations, in particular
those visiting friends and relatives and last-minute travel-
lers are at an increased (relative) risk of hepatitis B, which
may provide an extra argument for vaccination.
Interestingly, after completion of this study, the
Netherlands have changed their national childhood vacci-
nation programme by starting vaccinating all babies born on
or after the first of August 2011 against hepatitis B [16]. The
immunization rates against hepatitis B of future Dutch
travellers are therefore likely to increase further. Unfor-
tunately, the Dutch government decided not to institute a
catch up immunization campaign for children born before
this date [16]. As a consequence for the near future, Dutch
travel health care providers still have to consider the pos-
sibility of unprotected children and adolescents travelling
to hepatitis B risk destinations.Limitations
Questionnaire-based surveys may have several drawbacks
which may limit the generalizability of the currentfindings. First, cross-sectional questionnaire-based sur-
veys do not allow the evaluation of the impact of KAP on
actual incidence of hepatitis B cases among travellers
during the study period. In addition, risks for acquiring
hepatitis B may vary within a country and with each
possible hepatitis B risk situation like unprotected sexual
contact. We can therefore not truly speak of risk of hep-
atitis B but have to confine to relative risks instead. Sec-
ond, the classification of practice is based on
immunization rates but not on post-vaccination titres. As
a consequence, it is assumed that only vaccination results
in protection against hepatitis B but this may not be the
case for non-converting individuals and neglects the
impact of other preventive measures like condom use.
Third, the estimation of risk-taking or risk-avoiding
behaviour was based on previous journeys but attitudes
may change over time and may differ per journey.
Further, this study was designed to study the KAP of
certain frequently encountered travel risk groups to des-
tinations with a high or lower risk for hepatitis B and all
destinations were selected to meet this requirement. The
destinations were not randomly selected from all avail-
able risk destinations. In addition, the survey was always
done in the months October and November of each year,
which may have introduced a selection bias since people
who travel at this time of year may differ from people who
travel during other periods. Moreover, one could argue
that the traveller’s KAP profile including those belonging
to risk groups may be influenced by their prior travel
experience. To specifically address this potential
confounder, all questionnaires since 2004 contained
questions elaborating on this item. It appeared that as of
2004 travellers to high-risk destinations had more prior
travel experience than travellers to lower-risk destina-
tions (odds ratio of prior travel experience: 1.36; 95% CI:
1.07e1.72; p Z 0.011, adjusted for subpopulation).
Lastly, not all respondents belonged mutually exclusive to
one risk group; this might theoretically have confounded
the effect attributed to a certain characteristic of a risk
profile without adjusting for the other characteristics. For
judging potential mutual confounding of the travel risk
factors in their effect on KAP we calculated all correla-
tions between the risk factors; as the stronger correla-
tions differ from zero, the more confounding there may
be. It appeared that the only relevant correlation found
was that between business and solo-travellers
(r Z þ0.59). All other pairwise correlations were near
zero (varying between 0.19 and þ0.16). This means that
the effect of business travelling on KAP partly includes the
effect of solo travelling on KAP and vice versa, while be-
tween all other pairs of risk factors there will be hardly
any confounding. However, the interest of our study
focused on identifying travel risk groups rather than
theoretically disentangling the effects of the various risk
characteristics. The present study was also not designed
to study the KAP of long-term travellers toward hepatitis
B. All travellers with a travel duration exceeding 4 weeks
were grouped in this study, whereas hepatitis B vaccina-
tion is usually advised for travel duration exceeding >3
months. However, as compared to travel <4 weeks,
travellers with a travel duration of 4 weeks or more had
significantly more past-risk taking behaviour (14.4 (95% CI
158 P.J.J. van Genderen et al.11.2e17.6)) but significantly higher protection rates
(52.8% (95% CI 44.3e61.2%)), suggesting that these oppo-
site effects on KAP cancel each other out (data not
shown).
In conclusion, the results of this repeated cross-sectional
survey suggest an annual 10% increase in immunization rates
against hepatitis B in Dutch travellers, both to destinations
with a high risk and a lower risk of hepatitis B, but these
promising trends were not observed in the predefined travel
risk groups to high-risk destinations. The KAP profile of last-
minute travellers and (to a lesser extent) VFRs increased
their relative risk for hepatitis B, irrespective of the travel
destination, underlining the continuous need for specific
targeting of particularly these travel risk groups.
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